Novartis’ Zolgensma study halted by FDA amid safety questions
The US Food and Drug Administration's partial hold on the so-called STRONG trial impacts patients aged up to five with spinal…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.